LOGIN

Solving the Chinese puzzle: What determines reimbursement price in China?

Yearly Archives: 2022

Solving the Chinese puzzle: What determines reimbursement price in China?

  • By Song X, Kodabuckus S, Patel P
  • 23 December 2022
Read More

Regulatory and reimbursement landscape for Cell and Gene Therapies across Europe

  • By Beards S, Song X, Kodabuckus S
  • 23 December 2022
Read More

Suitability of value-based price forecasting in a crowded landscape: A case study in rheumatoid arthritis

  • By Anstee K, Patel P
  • 13 December 2022
Read More

The relationship between value and price in the free-pricing period and post-assessment price in Germany, a case study in rheumatoid arthritis

  • By Cigerli S, Anstee K, Patel P
  • 3 December 2022
Read More

State Price Transparency Reporting: 4 strategies to reduce the risk of non-compliance

  • 23 November 2022
Read More

Starting with the end in mind – creating sustainable access to medicines

  • 9 November 2022
Read More

GPI launches new unique platform solution, GPI horizon

  • 7 November 2022
Read More

Stairway to Seven: GPI celebrating 7 years in business

  • 29 September 2022
Read More

GPI demonstrates the strength of forecasting ability across market-specific value frameworks

  • By Kate Anstee
  • 27 July 2022
Read More

The National Pricing and Reimbursement Process in China: A 2021 Update

  • 25 June 2022
Read More

Previous Posts

Stay Informed

Sign up to receive the latest news and trends
straight into your inbox from GPI